Abstract : Strokes were significantly reduced by the combination of rivaroxaban plus aspirin compared with aspirin in the COMPASS Trial. We present detailed analyses of stroke by type, predictors, and antithrombotic effects in key subgroups.
Résumé : URL: https://www.clinicaltrials.gov Unique Identifier: NCT01776424.
